期刊文献+

孕激素维持妊娠及防治产科并发症新进展 被引量:7

New progress on progesterone maintaining pregnancy and preventing obstetric complications
下载PDF
导出
摘要 孕激素是维持妊娠所必需,在内膜转化、胚胎着床、母-胎免疫及子宫收缩方面均起到重要的调节作用。长久以来,孕激素作为先兆流产的治疗方法,疗效一直存在争议,最近的荟萃分析由于入组的高质量研究有限仍无法得出确切的结论。相反,孕激素在复发性流产患者中的疗效得到大部分文献的肯定和支持。此外,随着孕激素维持妊娠机制的研究深入,部分研究开始将孕激素应用于一些新的领域并显示出一定的效果,例如防治早产、预防妊娠期高血压及治疗胎儿宫内生长受限等。本文综述孕激素的作用机制及其在临床的应用情况,并对其给药途径进行简单比较。 Progesterone is necessary for the maintenance of pregnancy,and it also plays an important regulatory role in endometrial transformation, embryo implantation, maternal-fetal immunity and uterine contractions. For a long time,the progesterone efficacy as a treatment for threatened miscarriage has been controversial,and recent meta-analyses have failed to draw definite conclusions due to limited high quality research. In contrast, the efficacy of progesterone in treating patients with recurrent miscarriage is supported by most of the literatures. In addition, according to the publication of in-depth study, progesterone has been applied to new areas and shows some effects, such as prevention or treatment of preterm birth, gestational hypertension and fetal intrauterine growth restriction. This article reviews the effective mechanism of progesterone and its clinical application and compares different routes of its administration.
作者 徐匆 赵爱民 XU Cong ZHAO Ai-min(Department of Obstetrics& Gynecology, Renji Hospital, Shanghai Jiao-Tong University, Shanghai 20008)
出处 《生殖医学杂志》 CAS 2017年第8期838-842,共5页 Journal of Reproductive Medicine
关键词 先兆流产 复发性流产 早产 妊娠期高血压 地屈孕酮 Threatened miscarriage Recurrent miscarriage Preterm birth Gestational hypertension Dydrogesterone
  • 相关文献

参考文献2

二级参考文献63

  • 1曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004:2163-2169.
  • 2谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 3Devoto L, Fuentes A, Kohen P, et al. The human corpus luteum: life cycle and function in natural cycles. Fertil Steril, 2009, 92(3): 1067-79.
  • 4Chabbert Buffet N, Djakoure C, Maitre SC, et ai. Regulation of the human menstrual cycle, Front Neuroendocrinol, 1998, 19(3):151-86.
  • 5Szekeres-Bartho J, Wilczynski JR, Basta P, et al. Role of progesterone and progestin therapy in threatened abortion and preterm labour. Front Biosci, 2008, 13:1981-90.
  • 6Csapo AI, Pulkkinen MO, Wiest WG. Effects of lutectomy and progestreone replacement therapy in early pregnancy patients. Am J Obstet Gynecol, 1973, 115(6):759-65.
  • 7Messinis I, Messini C, Dafopoulos K. Luteal-phase endocrinology. Reprod Biomed Online, 2009, 19(4):4314.
  • 8Fatemi HM. The luteal phase after 3 decades of IVF: what do we know? Reprod Biomed Online, 2009, 19(4):4331.
  • 9Vaisbuch E, de Ziegler D, Leong M, et al. Luteal-phase support in assisted reproduction treatment: real-life practices reported world wide by an updated website-based survey. Reprod Biomed Online, 2014, 28(3):330-5.
  • 10Yanushpolsky E, Hurwitz S, Greenberg L, et al. Patterns ofluteal phase bleeding in in vitro fertilization cycles supple- mented with Crinone vaginal gel and with intramuscular progesterone-impact of luteal estrogen: prospective, randomized study and post hoc analysis. Fertil Steril, 2011, 95(2):617-20.

共引文献729

同被引文献63

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部